AV006 Design: Endpoints
Primary
- 1st episode of cx-confirmed influenza illness anytime on the day of or after receipt of 2nd dose of study vaccine.
Secondary
- 1st episode of cx-confirmed influenza illness occurring at least 15 days after the 1st dose of study vaccine in a subject after:
- receipt of 1 or 2 doses
- enrolled to receive 2-doses
- enrolled to receive 1 dose